← All companies

GNTA

Genenta Science S.p.A.

GNTA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.41

-0.10 -6.62%

Key statistics

from XBRL data in SEC filings

Market cap

$33.0M

Revenue (TTM)

—

Net income (TTM)

-$6.53M

EPS (TTM)

$-0.33

P/E ratio

—

Dividend yield

—

Free cash flow

-$6.88M

Cash

$25.7M

Total assets

$31.9M

Gross margin

—

52-week range

$0.55 – $10.00

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 31, 2026 6-K Jul 14, 2026 6-K Jul 1, 2026 6-K Jun 26, 2026 6-K Jun 24, 2026 6-K Jun 17, 2026 6-K Jun 16, 2026 6-K May 29, 2026 6-K May 19, 2026 6-K Apr 28, 2026 6-K Apr 23, 2026 6-K Apr 14, 2026 20-F Apr 1, 2026 6-K Mar 27, 2026 6-K Mar 24, 2026 6-K Jan 27, 2026 6-K Jan 27, 2026 6-K Nov 4, 2025 6-K Oct 28, 2025 6-K Oct 27, 2025 6-K Oct 10, 2025 6-K Oct 3, 2025 6-K Sep 10, 2025 6-K Aug 1, 2025 20-F Mar 28, 2025 6-K Mar 19, 2025 6-K Mar 19, 2025 6-K Dec 30, 2024 6-K Dec 20, 2024 6-K Dec 13, 2024 6-K Nov 14, 2024 6-K Oct 29, 2024 6-K May 3, 2024 6-K Apr 26, 2024 6-K Apr 8, 2024 6-K Apr 2, 2024 20-F/A Apr 1, 2024 20-F Mar 29, 2024 6-K Oct 20, 2023 6-K Jun 14, 2023